Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of the combination of Methenamine + Methylthioninium chloride compared to phenazopyridine (comparator product) in the symptomatic relief of dysuria.


Clinical Trial Description

- Single blind, randomized, prospective study.

- Length of experience: 03 days to 07 days.

- 03 visits (days 1, 4 and 7).

- Evaluation of the efficacy and safety of the medication.

- Shall be assessed for adverse events. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01657448
Study type Interventional
Source EMS
Contact
Status Completed
Phase Phase 3
Start date June 27, 2016
Completion date December 22, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05439902 - Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women N/A
Completed NCT02554201 - Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction N/A
Terminated NCT03185169 - GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors Early Phase 1
Completed NCT03474887 - Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care
Active, not recruiting NCT01563796 - Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer N/A
Completed NCT04228692 - Percutaneous Posterior Tibial Nerve Stimulation in Post-operative Voiding Dysfunction After Deep Endometriosis Surgery N/A
Completed NCT03210038 - Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia? N/A
Not yet recruiting NCT05156502 - To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated Laser N/A
Terminated NCT05152199 - Pain Outcomes During Rigid Cystoscopy in Females With and Without Cystoscopic Sheath Obturator N/A
Not yet recruiting NCT00969254 - Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria Phase 3
Terminated NCT03537534 - Intraurethral Lidocaine After Endourology Procedures Phase 3